PHASIQ
A cheaper, faster, and more accurate solution to test for multiple proteins on a single patient sample.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Seed | ||
| Total Funding | 000k | ||
Related Content
Phasiq.bio specializes in developing advanced multiplex immunoassays, which are tests that can measure multiple biomarkers simultaneously in a single sample. These assays are crucial for clinical diagnostics and biomedical research, providing high precision and efficiency. The company serves a diverse range of clients, including pharmaceutical companies, research institutions, and clinical laboratories. Operating in the biotechnology market, Phasiq.bio's business model revolves around the sale of its proprietary assay kits and related services. Revenue is generated through direct sales, partnerships, and licensing agreements.
Keywords: multiplex immunoassays, biomarker analysis, clinical diagnostics, biomedical research, pharmaceutical, biotechnology, assay kits, precision, efficiency, proprietary technology.